Preview Mode Links will not work in preview mode

Feb 15, 2019

Contact us:

  1. FDA panels back intranasal esketamine for refractory depression.
  2. ONC aims to help doctors, patients with information sharing in proposed rule.
  3. Survey: Health care costs unlikely to improve in 2019.
  4. Vaccination and antiviral treatment don't lower stroke risk after shingles.